The aim of this study was to identify the rate and repertoire of TP53 somatic mutations and the prevalence of the TP53 R72 (arginine) SNP, as well as the relationship between these parameters in a cohort of both HPV(+) and HPV(−) HNSCC patients. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.